Company intelligence / Profile preview

诺禾心康

北京市海淀区（Haidian District）, 北京市（Beijing）, 中国（China）

Ownership: Private
Development stage: Other

Overview

诺禾心康 specializes in genetic testing for cardiovascular diseases using advanced high-throughput sequencing technologies. The company provides both clinical diagnostic services and supports scientific research collaborations. It leverages the large-scale sequencing capabilities of its parent company to deliver accurate gene-based insights for chronic disease management. The company has established itself as a leading provider in this niche within China’s biotech sector.

Therapeutic areas: CardiovascularEndocrinology
Modalities: Genetic testinghigh-throughput sequencing
Industry: Molecular Diagnostics

Partnerships

Collaborates with hospitals and research institutions for clinical application of its tests. No specific partners named in public sources.

Beyond the preview

Go deeper on 诺禾心康.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 诺禾心康.

Explore the full profile